Skip to main content

Table 2 Comorbidities in the two groups who concluded the study (n = 816)

From: Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)

 

NO ICS (n = 334)

ICS (n = 334)

p-value

Cardiovascular

52%

64%

0.001

Obesity

17%

19%

0.523

Gastric reflux

13%

14%

0.918

Diabetes

13%

12%

0.787

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us